Search for: "In Re: Fosamax v."
Results 1 - 20
of 109
Sort by Relevance
|
Sort by Date
12 Mar 2024, 12:46 pm
Moye from giving such testimony); In re Rezulin Products Liab. [read post]
30 Mar 2022, 7:01 pm
Worth our note is a recent preemption decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation, 2022 WL 855853 (D.N.J. [read post]
24 Mar 2022, 11:25 am
Supreme Court made a ruling on the federal preemption legal issue in these Fosamax cases in May 2019 (see Merck Sharp & Dohme Corp. v. [read post]
23 May 2019, 9:30 pm
Court of Appeals for the Third Circuit, which held that a jury should determine if FDA would have added a warning to the labels of Merck osteoporosis drug Fosamax. [read post]
2 May 2019, 10:44 am
Litig., 858 F.3d 787 (3d Cir. 2017) (affirming MDL trial court’s Rule 702 exclusions of opinions that Zoloft is teratogenic); (5) Jones v. [read post]
9 Jan 2019, 4:16 am
Richard Re previewed the case for this blog. [read post]
8 Jan 2019, 6:32 am
The Supreme Court opened its January session Monday morning with argument in Merck Sharp & Dohme Corp. v. [read post]
10 Sep 2018, 10:17 am
The outcome in Acorda v. [read post]
17 Oct 2015, 5:29 am
In re Paoli RR Yard PCB Litig., 35 F.3d 717, 745 (3d Cir. 1994). [read post]
24 Aug 2015, 5:00 am
McNeil Consumer Healthcare, 615 F.3d 861 (7th Cir. 2010); In re Fosamax, 951 F. [read post]
13 Aug 2015, 10:56 am
In Shah v. [read post]
26 May 2015, 7:42 am
So far many plaintiffs have had trouble coming up with factual support to back such allegations – and sometimes we’re not even sure why they’re making them. [read post]
31 Dec 2014, 5:00 am
We hope that your 2014 was pleasant and (if you’re on our side of the “v. [read post]
7 Nov 2014, 5:52 am
Parke, Davis & Co., 256 F.3d 1013, 1021 (10th Cir. 2001) (wrong to “construe [a treater’s] ‘heeding’ an adequate warning to mean [s/he] would have given the warning”) (applying Oklahoma law); In re Diet Drug Litigation, 895 A.2d 480, 490-91 (N.J. [read post]
22 Aug 2014, 9:22 am
Similarly in In re Fosamax Litigation, 2012 WL 181411 (D.N.J. [read post]
12 Jun 2014, 3:11 pm
See In re Fosamax Prods. [read post]
1 May 2014, 4:59 am
So we read the decision in In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (Gannon), No. 3:13-cv-10143-DRH-PMF, 2014 U.S. [read post]
30 Apr 2014, 10:11 am
Thanks to Terry Henryat Blank Rome for sending along today’s preemption decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation (No. [read post]
29 Apr 2014, 1:13 pm
Parkinson v. [read post]
22 Apr 2014, 10:45 am
The plaintiff in Jennings v. [read post]
